BT Slingsby
Dr. BT Slingsby is CEO and executive director of the GHIT Fund. Previously, he was director for Global Access Strategies for Eisai Co., Ltd. where he developed new business models for R&D and market access in the developing world. Prior to joining Eisai Co., Ltd., he helped launch numerous startups in Japan and the U.S.
Latest Articles
How innovative financing and partnerships are transforming the infectious disease product pipeline
over 10 years ago // #innov8aid
Through the Global Health Innovative Technology Fund, the Japanese works with pharmaceutical companies and nonprofits to boost investment in the research and development of game-changing drugs for the world's deadliest diseases. GHIT CEO and Executive Director BT Slingsby explains how the fund works.